Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Outpatient Oncology Infusion Industry Expected To Reach By 2029, Starting From 2025 Levels?
The outpatient oncology infusion market has experienced substantial expansion in recent years. This market is projected to expand from $12.99 billion in 2024 to $14.02 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.9%. Historically, this upward trend has been propelled by several factors including the increasing occurrence of cancer, the proliferation of outpatient centers, patients’ preference for home-like treatment environments, expanded insurance coverage, the transition from inpatient to outpatient care models, and improved survival statistics.
The market size for outpatient oncology infusion is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $18.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.6%. Key factors driving this growth during the forecast period include an expanding elderly demographic, increasing demand for customized medicine, greater adoption of biosimilars, an emphasis on managing costs, the implementation of value-based reimbursement frameworks, and deficits in the labor force. Noteworthy trends anticipated during the forecast period encompass progress in infusion technologies, the incorporation of telehealth services, remote patient monitoring facilitated by technology, breakthroughs in personalized medicine, and refinements in targeted therapeutic approaches.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp
What Are The Drivers Pushing New Developments In The Outpatient Oncology Infusion Market?
The rising incidence of cancer diagnoses is anticipated to fuel the expansion of the outpatient oncology infusion market moving forward. Cancer encompasses a range of intricate diseases marked by the uncontrolled proliferation of abnormal cells, which can invade adjacent tissues and spread to other parts of the body. The increasing occurrence of cancer cases is primarily attributable to aging populations globally, as the likelihood of developing cancer significantly increases with age. Outpatient oncology infusion is utilized to deliver cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical setting without requiring hospital admission, allowing patients to receive care while sustaining their daily routines. For instance, in April 2024, according to Macmillan Cancer Support, a UK-based charity providing practical, emotional, and financial support to people affected by cancer, it is projected that the number of individuals living with cancer in the UK will exceed 3 million presently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the growing prevalence of cancer cases is driving the growth of the outpatient oncology infusion market.
What Are The Major Segments Identified In The Outpatient Oncology Infusion Market?
The outpatient oncology infusion market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors
What Are The Latest Industry Trends Transforming The Outpatient Oncology Infusion Market?
Major companies operating in the outpatient oncology infusion market are focusing on innovative products such as syringe infusion pumps to enhance infusion accuracy, improve patient safety, and streamline medication delivery through advanced software and dose error reduction systems. A syringe infusion pump, also recognized as a syringe driver, is a motorized device designed to precisely control the flow of fluids by mechanically advancing or retracting the plunger of a syringe. For instance, in August 2022, Baxter International Inc., a US-based healthcare company specializing in surgical and intravenous infusion technologies, received U.S. Food and Drug Administration (FDA) clearance for the Novum IQ Syringe Infusion Pump (SYR), which is integrated with the Dose IQ Safety Software. This system utilizes Baxter’s advanced, web-based Dose IQ platform featuring a customizable drug library and a dose error reduction mechanism designed to support clinicians and healthcare institutions by centralizing real-time access to the latest medication data. Specifically intended for outpatient healthcare environments, including outpatient oncology infusion settings, the system delivers accurate, programmable infusions of therapeutic agents across diverse clinical care settings.
Which Major Industry Participants Are Leading The Outpatient Oncology Infusion Market Growth?
Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report
Which Region Currently Holds The Largest Share Of The Outpatient Oncology Infusion Market?
North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Outpatient Oncology Infusion Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp
Browse Through More Reports Similar to the Global Outpatient Oncology Infusion Market 2025, By The Business Research Company
Home Infusion Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report
Chemotherapy Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemotherapy-infusion-pumps-global-market-report
Drug Infusion Systems Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model